532989 Stock Overview
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Bafna Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹87.30 |
| 52 Week High | ₹125.55 |
| 52 Week Low | ₹76.50 |
| Beta | 0.50 |
| 1 Month Change | 4.05% |
| 3 Month Change | -14.33% |
| 1 Year Change | -0.78% |
| 3 Year Change | -34.11% |
| 5 Year Change | n/a |
| Change since IPO | 1,562.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532989 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.3% | -2.8% | -1.5% |
| 1Y | -0.8% | 54.9% | 45.0% |
Return vs Industry: 532989 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 532989 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 532989 volatility | |
|---|---|
| 532989 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532989 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532989's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 588 | Bansilal Mahaveer Bafna | www.bafnapharma.com |
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products.
Bafna Pharmaceuticals Limited Fundamentals Summary
| 532989 fundamental statistics | |
|---|---|
| Market cap | ₹2.06b |
| Earnings (TTM) | ₹112.64m |
| Revenue (TTM) | ₹1.53b |
18.3x
P/E Ratio1.3x
P/S RatioIs 532989 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532989 income statement (TTM) | |
|---|---|
| Revenue | ₹1.53b |
| Cost of Revenue | ₹1.07b |
| Gross Profit | ₹463.83m |
| Other Expenses | ₹351.19m |
| Earnings | ₹112.64m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.76 |
| Gross Margin | 30.25% |
| Net Profit Margin | 7.35% |
| Debt/Equity Ratio | 20.1% |
How did 532989 perform over the long term?
See historical performance and comparison